Nectero Medical Announces Completion of $96M Series D Financing
Nectero Medical Announces Initiation of Phase II/III Clinical Trial of the Nectero EAST® System for Treatment of Small- to Medium-Sized Abdominal Aortic Aneurysms
Nectero Medical Granted Breakthrough Therapy Designation for the Nectero EAST® System to Treat Infrarenal AAA
Nectero Medical Receives FDA Fast Track Designation for Nectero EAST® System